Details

Marriott Marquis Chicago, 2121 S Prairie Avenue, Chicago, Illinois, 60616  — Room: Grand Horizon Ballroom ABC (Level 4)

Supported By: Madrigal Pharmaceuticals

Program Description

The incidence of metabolic dysfunction-associated steatohepatitis (MASH) is growing rapidly. Patients with or at risk for MASH are underdiagnosed, and thus they may not be benefiting from newly approved liver-directed therapies that can alter the disease course. In this “Test and Teach” style symposium, attendees will be challenged to answer clinical questions about realistic patient cases presented by expert faculty. Faculty will provide real-time feedback on clinical decision-making and “teach” on important topics, including the interconnections between MASH and other chronic metabolic diseases, noninvasive testing strategies, risk stratification, and the latest clinical data on newly approved and emerging treatments for MASH. Join us for this fun and informative case challenge!

For more information and to register, please visit: www.medscape.org/symposium/mash-pathway-2025

Target Audience
This educational activity is intended for an audience of diabetologists/endocrinologists, nurse practitioners, physician assistants, and other healthcare practitioners who treat patients with metabolic dysfunction-associated steatotic liver disease (MASLD)/MASH in the United States.

Goal Statement
The goal of this activity is for learners to be better able to integrate the evidence-based MASH care pathway for assessment and treatment decisions into clinical practice.

Learning Objectives
Upon completion of this activity, participants will:

Have increased knowledge regarding the

• Current evidence for MASH therapies

Have greater competence related to

• Implementing sequential non-invasive tests to risk-stratify patients with MASH
• Selecting evidence-based treatments for patients with MASH

Accreditation Statement
In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

For Physicians
Medscape, LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Speakers

Moderator
Fernando Bril, MD
University of Alabama at Birmingham
Department of Medicine – ​Division of Endocrinology, Diabetes, and Metabolism
Assistant Professor
Birmingham, AL

Panelist
Meena B. Bansal, MD, FAASLD
Icahn School of Medicine at Mount Sinai
Director of Translational Research, Liver Diseases
Professor of Medicine
New York, NY

Panelist
Christos S. Mantzoros, MD, DSc, PhD
Harvard Medical School
Boston University School of Medicine
​Professor of Medicine
Boston, MA

---

Resources

For more information and to register, click here!